Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T-regulatory Homing Subsets as a Predictor of Response in GVHD Treated With Extracorporeal Photopheresis

NCT01324908 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT01324908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01324908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T-regulatory Homing Subsets as a Predictor of Response in GVHD Treated With Extracorporeal Photopheresis
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2011
Completion date
November 16, 2020
Enrollment
85 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease (gvhd)